Breast Imaging: Page 82

Digital breast tomosynthesis boosts reader accuracy, cuts recall rate

By Kathlyn Stone

Digital breast tomosynthesis (DBT) boosts radiologists' cancer detection rates compared to full-field digital mammography (FFDM) alone, according to a multicenter, multireader study that evaluted reader performance with DBT. For this study, a dozen radiologists at five clinics took part in the trial, which compared radiologists' cancer detection rates and screening recall rates using DBT.

December 27, 2007

Preop MRI can improve breast cancer surgical outcomes, study says

By Kate Madden Yee

The use of MRI for the diagnosis and staging of breast cancer remains controversial, with some clinicians advocating for its use and others claiming that its value is unproven. Despite all this attention, whether breast MRI positively influences surgical outcomes in women with diagnosed breast cancer has not yet been studied extensively.

December 26, 2007

RSNA studies advance ultrasound's role in breast cancer detection

By Edward Susman

The preliminary results of the ACRIN 6666 trial show that ultrasound boosts cancer detection but at the risk of a higher false-positive rate. While the trial investigators continue to mine the trial data to find the best place for the modality in a screening setting, other researchers are using advanced imaging technology such as 3D and computer-aided analysis tools with ultrasound to enhance breast imaging.

December 25, 2007

DBT reduces mammo recalls; getting paid for FFDM

By Brian Casey

December 19, 2007

Digital breast tomo cuts callback rate in screening setting

By Shalmali Pal

If a picture is worth a 1,000 words, then the digital breast tomosynthesis (DBT) images are undeniably powerful: lesions that manage to hide on conventional mammography exams are easily exposed by DBT. But does this dramatic improvement in tissue visualization lead to significant changes in the cancer screening setting? Yes, according to researchers at Boston's Massachusetts General Hospital (MGH). They noted a marked reduction in the callback rate for women screened with tomosynthesis at MGH.

December 19, 2007

Hamartoma with digital breast tomosynthesis

DBT has demonstrated the ability to reduce false-positive results.

December 2, 2007

Dexela awarded development grant

By AuntMinnie.com staff writers

Breast imaging developer Dexela of London has been awarded a grant for 360,000 pounds ($ 744,156 U.S.) by U.K.'s Technology Strategy Board as part of a collaborative research and development program to improve digital breast tomosynthesis (DBT) for early breast cancer detection.

November 27, 2007

Confirma, PenRad streamline breast MRI reporting

By AuntMinnie.com staff writers

Computer-aided detection (CAD) developer Confirma and PenRad Technologies are showcasing the new integration between CADstream for breast MRI and the PenRad Mammography Information System (MIS) at this week's RSNA 2007 meeting in Chicago.

November 26, 2007

DBT: Not a panacea, but promising technology is unfairly panned

By Dr. Daniel Kopans

The debate over the relative value of digital breast tomosynthesis (DBT) for cancer screening continues with Dr. Daniel Kopans, founder of the breast imaging division at Massachusetts General Hospital in Boston, who offers an opinion on the technology.

October 29, 2007

Aurora breast MRI goes mobile in Italy

By AuntMinnie.com staff writers

Aurora Imaging Technology of North Andover, MA, said its mobile Aurora 1.5-tesla dedicated breast MRI system is heading for Italy.

August 8, 2007

MRI beats US for breast screening of at-risk women, but yields more biopsies

By Shalmali Pal

A new study in Radiology has found that MRI beats ultrasound when used as a complement to mammography in monitoring women at high risk of developing breast cancer. The study adds further weight to arguments that MRI should play a major role as an adjunct in screening high-risk women.

August 5, 2007

Study: CAD helpful for breast MRI

By AuntMinnie.com staff writers

Computer-aided detection (CAD) for breast MRI may improve standardization and the analysis of benign and malignant lesions. Researchers from Seattle conducted a retrospective examination of 154 breast lesions deemed suspicious by radiologists that were only visible on MRI and that had been biopsied under MRI guidance.

June 27, 2007

Previous Page

Page 82 of 87

Next Page